CN101518621B - 抗氧化和增强免疫力的金钗石斛胶囊 - Google Patents
抗氧化和增强免疫力的金钗石斛胶囊 Download PDFInfo
- Publication number
- CN101518621B CN101518621B CN2009100942596A CN200910094259A CN101518621B CN 101518621 B CN101518621 B CN 101518621B CN 2009100942596 A CN2009100942596 A CN 2009100942596A CN 200910094259 A CN200910094259 A CN 200910094259A CN 101518621 B CN101518621 B CN 101518621B
- Authority
- CN
- China
- Prior art keywords
- dendrobium nobile
- nobile lindl
- capsule
- lindl
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000004638 Dendrobium nobile Species 0.000 title claims abstract description 91
- 239000002775 capsule Substances 0.000 title claims abstract description 36
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 13
- 230000003647 oxidation Effects 0.000 title abstract description 5
- 238000007254 oxidation reaction Methods 0.000 title abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 230000003064 anti-oxidating effect Effects 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 39
- 239000013642 negative control Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 230000000242 pagocytic effect Effects 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 210000003024 peritoneal macrophage Anatomy 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 人数 | 试食前MDA(nmoL/mL) | 试食后MDA(nmoL/mL) | P值(自身) | 下降率(%) |
对照组 | 50 | 4.36±0.72 | 4.12±0.87 | P>0.05 | 4.53 |
试食组 | 50 | 4.51±0.98 | 2.75±1.77 | P<0.01 | 37.01 |
P值(组间) | -- | P>0.05 | P<0.01 | -- | P<0.01 |
组别 | 人数 | 试食前SOD(NU/mL) | 试食后SOD(NU/mL) | P值(自身) | 升高率(%) |
对照组 | 50 | 85.15±16.13 | 86.51±14.21 | P>0.05 | 2.01 |
试食组 | 50 | 82.93±15.68 | 83.75±15.14 | P>0.05 | 3.13 |
P值(组间) | -- | P>0.05 | P>0.05 | -- | P>0.05 |
组别 | 人数 | 试食前GSH-Px(NU/mL) | 试食后GSH-Px(NU/mL) | P值(自身) | 升高率(%) |
对照组 | 50 | 110.65±17.62 | 104.89±18.16 | P>0.05 | -3.26 |
试食组 | 50 | 109.14±18.78 | 115.32±17.64 | P<0.05 | 8.34 |
P值(组间) | -- | P>0.05 | P<0.05 | -- | P<0.05 |
剂量组(mg/kg BW) | 动物数(只) | 淋巴细胞增殖能力(OD值) | P值 |
360 | 12 | 1.626±1.193 | 0.001 |
180 | 12 | 0.758±0.176 | 0.411 |
90 | 12 | 0.501±0.203 | 0.902 |
阴性对照 | 12 | 0.411±0.295 | --- |
剂量组(mg/kg BW) | 动物数(只) | 左右耳片重量差值(mg) | P值 |
360 | 12 | 11.24±2.10 | 0.087 |
180 | 12 | 11.09±2.23 | 0.186 |
90 | 12 | 10.21±2.26 | 0.624 |
阴性对照 | 12 | 9.57±1.87 | --- |
剂量组(mg/kgBW) | 动物数(只) | (1×103/全脾) | P值 |
360 | 12 | 228.21±21.49 | 0.041 |
180 | 12 | 217.38±24.39 | 0.346 |
90 | 12 | 211.02±28.35 | 0.751 |
阴性对照 | 12 | 201.05±29.00 | --- |
剂量组(mg/kg BW) | 动物数(只) | 抗体积数 | P值 |
360 | 12 | 167.22±18.67 | 0.001 |
180 | 12 | 162.64±17.13 | 0.002 |
90 | 12 | 154.29±21.27 | 0.027 |
阴性对照 | 12 | 133.34±16.02 | --- |
剂量组(mg/kg BW) | 动物数(只) | 吞噬指数 | P值 |
360 | 12 | 10.69±1.38 | 0.001 |
180 | 12 | 9.96±1.52 | 0.006 |
90 | 12 | 8.58±1.59 | 0.674 |
阴性对照 | 12 | 7.98±1.21 | --- |
剂量组(mg/kg BW) | 动物数(只) | 吞噬率(%) | 吞噬指数数据转换 | P值 | 吞噬指数 | P值 |
360 | 12 | 47.12±13.16 | 0.712±0.112 | 0.001 | 0.854±0.394 | 0.001 |
180 | 12 | 39.22±9.13 | 0.617±0.100 | 0.006 | 0.756±0.284 | 0.012 |
90 | 12 | 28.33±9.12 | 0.534±0.098 | 0.751 | 0.514±0.192 | 0.641 |
阴性对照 | 12 | 23.12±8.68 | 0.521±0.095 | --- | 0.398±0.239 | --- |
剂量组(mg/kg BW) | 动物数(只) | NK细胞活性(%) | NK细胞活性数据转换 | P值 |
360 | 12 | 58.01±10.10 | 0.891±0.173 | 0.001 |
180 | 12 | 40.97±10.83 | 0.627±0.124 | 0.001 |
90 | 12 | 29.11±8.37 | 0.512±0.074 | 0.002 |
阴性对照 | 12 | 13.80±11.86 | 0.368±0.164 | --- |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100942596A CN101518621B (zh) | 2009-03-27 | 2009-03-27 | 抗氧化和增强免疫力的金钗石斛胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100942596A CN101518621B (zh) | 2009-03-27 | 2009-03-27 | 抗氧化和增强免疫力的金钗石斛胶囊 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101518621A CN101518621A (zh) | 2009-09-02 |
CN101518621B true CN101518621B (zh) | 2011-09-28 |
Family
ID=41079552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100942596A Expired - Fee Related CN101518621B (zh) | 2009-03-27 | 2009-03-27 | 抗氧化和增强免疫力的金钗石斛胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101518621B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102318823B (zh) * | 2011-10-07 | 2012-07-25 | 刘和勇 | 一种石斛营养粉 |
CN102669664A (zh) * | 2012-05-14 | 2012-09-19 | 贵州省赤水市金钗石斛产业开发有限公司 | 一种抗氧化和增强免疫力的金钗石斛胶囊及其制作方法 |
CN110559394A (zh) * | 2018-06-06 | 2019-12-13 | 捷通国际有限公司 | 包含金钗石斛的组合物及其使用方法 |
CN112189735A (zh) * | 2020-10-26 | 2021-01-08 | 江苏农牧科技职业学院 | 一种能够提高免疫力的金钗石斛与绿茶组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533801A (zh) * | 2003-03-31 | 2004-10-06 | 深圳康泰生物制品股份有限公司 | 金钗石斛提取物及其药物组合物 |
CN101015649A (zh) * | 2006-11-23 | 2007-08-15 | 天津市轩宏医药技术有限公司 | 一种铁皮石斛多糖提取物、其药物组合物和其制备方法及其应用 |
CN101380422A (zh) * | 2008-07-10 | 2009-03-11 | 陶国闻 | 抗氧化和清咽的铜皮石斛胶囊 |
-
2009
- 2009-03-27 CN CN2009100942596A patent/CN101518621B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533801A (zh) * | 2003-03-31 | 2004-10-06 | 深圳康泰生物制品股份有限公司 | 金钗石斛提取物及其药物组合物 |
CN101015649A (zh) * | 2006-11-23 | 2007-08-15 | 天津市轩宏医药技术有限公司 | 一种铁皮石斛多糖提取物、其药物组合物和其制备方法及其应用 |
CN101380422A (zh) * | 2008-07-10 | 2009-03-11 | 陶国闻 | 抗氧化和清咽的铜皮石斛胶囊 |
Non-Patent Citations (4)
Title |
---|
张雪 等."金钗石斛中的倍半萜类化合物".《中草药》.2007, |
王刚."金菟亮光胶囊的药学研究".《中国优秀硕士学位论文全文数据库医药卫生科技辑》.2008,第(实际无记载)卷(第02期),E057-302. |
王刚."金菟亮光胶囊的药学研究".《中国优秀硕士学位论文全文数据库医药卫生科技辑》.2008,第(实际无记载)卷(第02期),E057-302. * |
钱桂敏 等."金钗石斛鲜品闪式提取方法的工艺研究".《中国实验方剂学杂志》.2008, |
Also Published As
Publication number | Publication date |
---|---|
CN101518621A (zh) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101491334B (zh) | 一种具有增强免疫力功能的保健食品 | |
CN103445165B (zh) | 一种用于改善亚健康状态的产品及其组合物 | |
CN103007146B (zh) | 一种增强记忆力的保健营养粉 | |
CN104323231A (zh) | 一种护肝醒酒天然组合物及制品与制备方法 | |
CN105029605A (zh) | 茉莉花养生酵素饮料的制备方法 | |
CN102934742B (zh) | 用于提高高邮麻鸭肉质的饲料 | |
CN102228250B (zh) | 一种改善睡眠的功能性食品及其制备方法 | |
CN101518621B (zh) | 抗氧化和增强免疫力的金钗石斛胶囊 | |
CN103181560B (zh) | 一种具有冬季养生保健作用的保健食品及其制备方法 | |
CN109247560A (zh) | 一种发酵型调味玫瑰花料酒及其制备方法 | |
CN105851185A (zh) | 一种具有抗疲劳功效的饼干及其制备方法 | |
CN101653249B (zh) | 一种降血糖增强免疫力的功能食品 | |
CN103750094A (zh) | 雄蜂蛹保健膏及其制备方法 | |
CN103330175B (zh) | 一种天然植物组合物调味品及其制备方法 | |
CN106333089A (zh) | 一种特色肉牛中草药饲料添加剂及其制备、饲用方法 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
CN101904501B (zh) | 一种缓解疲劳的功能食品及其制备方法 | |
CN105994740A (zh) | 铁皮石斛绿茶及其制备方法 | |
CN104664388A (zh) | 一种含人参、生姜、玉米胚芽蛋白的咀嚼片及其制备方法 | |
CN104082747A (zh) | 一种具有提高机体免疫力功能的保健食品及其制备方法 | |
CN108077908A (zh) | 一种清热消炎的三七茎叶酵素的制备方法及其应用 | |
CN101828703B (zh) | 一种增强机体免疫力并能改善睡眠质量的产品及制备方法 | |
CN111840465A (zh) | 一种黄精、人参、铁皮石斛叶中药复方组合物及其制备方法、制剂和应用 | |
CN103404701A (zh) | 一种改善禽畜肌肉口感的兽用组合物及其制备方法和用途 | |
CN102669664A (zh) | 一种抗氧化和增强免疫力的金钗石斛胶囊及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG JING Free format text: FORMER OWNER: TAO GUOWEN Effective date: 20141120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Jing Inventor before: Tao Guowen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650106 KUNMING, YUNNAN PROVINCE TO: 650000 KUNMING, YUNNAN PROVINCE Free format text: CORRECT: INVENTOR; FROM: TAO GUOWEN TO: WANG JING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141120 Address after: 650000 No. 7, Donghua 30, Donghua District, Guandu District, Yunnan, Kunming Patentee after: Wang Jing Address before: 650106 Yunnan city of Kunming province high tech Zone Haiyuan Road No. 6 building nine floor high tech investment Patentee before: Tao Guowen |
|
TR01 | Transfer of patent right |
Effective date of registration: 20211020 Address after: 101100 Room 101, 1f, building 1, yard 8, Taiping Street, Xicheng District, Beijing Patentee after: Shouyi Alliance Medical Research Institute (Beijing) Co.,Ltd. Address before: 650000 No. 30, courtyard 7, Donghuali, Donghua community, Guandu District, Kunming, Yunnan Province Patentee before: Wang Jing |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 |
|
CF01 | Termination of patent right due to non-payment of annual fee |